DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has ...

Lewes, Delaware, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Global Non-Invasive Prenatal Testing Market Size is projected to grow at a CAGR of 17.01% from 2024 to 2031, according to a new report published ...

SAN CARLOS, Calif., Dec. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest commercial health plan in ...

When Eryn Schultz was pregnant, her doctor recommended non-invasive prenatal testing (NIPT), a blood test that can look for genetic abnormalities and also detect a baby's sex. It would be covered by ...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global leader in bio-analytical testing, announces that it has closed the acquisition of GATC Biotech AG ...

In December 2022, the American College of Medical Genetics and Genomics made a recommendation that all expectant mothers should be offered non-invasive prenatal testing (NIPT) instead of traditional ...

The birth of every new life is to be celebrated. During the first trimester of pregnancy, doctors from the department of gynecology and obstetrics may suggest pregnant mothers undertake noninvasive ...

Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and the European leader in non-invasive prenatal testing (NIPT), announces that it has signed an agreement with ...

Natera says it has begun making good on its priorities for 2021, which include expansions in noninvasive prenatal testing (NIPT), transplant rejection testing, minimal residual disease (MRD) cancer ...